Cargando…
Bowel inflammation in cancer patients: the microbiome, antibiotics and interleukin-9
Microbiome composition can impact disease courses and also immunotherapy outcomes in solid tumours. It is still unclear how the microbiome might impact treatments in oncology, but also how modulation via antibiotics might interfere. Elegant work now identified interleukin-9 and dysbiosis as relevant...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652919/ https://www.ncbi.nlm.nih.gov/pubmed/32843683 http://dx.doi.org/10.1038/s41416-020-01030-0 |